Lilly was founded in 1876 by Colonel Eli Lilly. His ambition was creating quality medicines that met real needs, during a time of deceptive medicine being sold by con men.
Disease Areas
Eli lilly and Co. mainly focus on several types of diseases for their medicines.
- Diabetes
- Cancer
- Immunology
- Pain
- Neurodegradation
COVID-19 Response
On February 3rd, 2020, the company began to involves themselves in the pandemic by donating funds to the Red Cross and Direct Relief. On March 12th, it was announced that they would partner with AbCellera to develop antibody products in hopes to treat and prevent Covid-19.
A drive thru testing site was designated by the company, solely for health care workers, public safety, fire, ambulance, and public servants.
Timeline
June 24, 2021
Eli Lilly and Company launches the Leonard Award to recognize diverse champions dedicated to advancing diabetes management through innovative thinking and novel approaches.
April 13, 2021
Eli Lilly and Company announces that Diogo Rau will join the company as senior vice-president and chief information and digital officer.
February 1, 2021
Eli Lilly and Company partners with Area Health Systems to help enable access to important antibody infusion therapies for COVID-19 Patients.
November 19, 2020
Eli Lilly and Company and Ypsomed announces a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly's connected diabetes solutions.
November 5, 2020
Eli Lilly and Company announces that Aarti Shah, Ph.D., senior vice president and chief information and digital officer, will retire in the first half of 2021.
June 8, 2020
Eli Lilly and Company announces its partner Junshi Biosciences (HKEX: 1877) has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.
1875
Eli Lilly and Company was founded by Eli Lilly.
Products
Acquisitions
Invested in
Patents
Further Resources
Title
Author
Link
Type
Date
Lilly CEO Dave Ricks Shares Key Milestone in Fight Against COVID-19
Web
November 9, 2020
News
Title
Author
Date
Publisher
Description
FinSMEs
July 12, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Brandon May
July 6, 2021
BioSpace
Jardiance most recently received approval by the European Commission for the treatment of adult patients with HF with ejection fraction, based on findings from the EMPEROR-Reduced trial.
Mark Terry
June 29, 2021
BioSpace
Here's a look at some of the top COVID-19-related stories for today.
PharmStars
June 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- PharmStars, a digital-health accelerator that launched earlier this month, announces its founding pharma members: Boehringer Ingelheim, Eli...
Sohini Das
June 28, 2021
@bsindia
Eli Lilly has granted voluntary license to 6 Indian drugmakers for Baricitinib
SHOW MORE
References
...
Organization
Investor
CompanyCompany attributes
Pharmaceutical industry
Drug discovery
Biomedical engineering
Healthcare
Fermentation
Therapeutics
Lewy body
Clinton, Indiana
Indianapolis
Anaheim, California
San Diego
Cambridge, Massachusetts
United States
New York
New JerseyB2X
B2BCEO
David RicksFounder
Eli LillyPitchbook URL
Legal Name
Eli Lilly and Company
Parent Organization
Eli Lilly and Company
ImClone Systems
Lilly Ventures
Prevail Therapeutics
ARMO BioSciences
LILLYLegal classification
Joint-stock company
Public companyDate Incorporated
1875
Spinout
Lilly Asia VenturesNumber of Employees (Ranges)
10,000 – 49,999
Tagline
If it bears a Lilly red, it's right.
Full Address
893 Delaware St, Indianapolis, IN 46225 USA
10290 Campus Point Drive San Diego, CA 92121
1500 South Harding Street Indianapolis, IN 46221
235 Federico Costa Street Parque Las Américas I, Suite 401 San Juan, Puerto Rico 00918
33 ImClone Drive Branchburg, NJ 08876
400 Calle Fabril Carolina, Puerto Rico 00987
450 Kendall Street Cambridge, MA 02142
555 Twelfth Street NW Suite 650 South Washington, DC 20004
Place of Incorporation
IndianaInvestors
IpiNovyx BioDUNS Number
006421325
IRS Number
350,470,950
Founded Date
January 1, 1876
Phone Number
+12024341015
+17877537070
+13174331625
+13176517973
+18585974990
+13172762000
+18005455979
+17872575555
Competitors
Adagio Therapeutics
Cellular ResearchStock Symbol
LLY
New York Stock Exchange
Tokyo Stock ExchangeGlassdoor ID
Board of Directors
Juan Ricardo Luciano
J. Erik FyrwaldFormer CEO
Key People
Also Known As
LLY
Patents Assigned (Count)
796
Legal Entity Identifier
Other attributes
Patents
Country
Headquarters
Wikidata ID
Owner of
Norfolk House, BasingstokeNamed After
Company Operating Status
Active
Owner
Strategic Partnerships
IncyteFounder of
CortevaCategories
Related Topics
Contributors
- 1
Nico Faraguna
Video game fan with a passion for technology and pop culture. I make plastic rock climbing routes, too. - 2
Henry Ogolla
Passionate about reading and writing. - 3
Russell Cain
Student of international relationship faculty - 4
Aime Anne Nisay
Software QA of web and mobile applications - 5
Vitalii Mazuryk
I am interesting in crypto since 2020. Trying to develop and grow in this environment and be useful. I do my best! - 6
Duzenko Andrey
Extensive experience in development and interaction with the community - 7
Таня Гагарина
researcher kripto - 8
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 9
Дмитрий Гаращук
Digital marketing guru. Investor. Analyst. - 10
Amy Sar
Data acquisition Golden, computational linguist